Pyronaridine
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s. In a small (n=88) malaria study in Cameroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine. It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax). It has also been studied as a potential anticancer drug, and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.
Pyronaridine is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s. In a small (n=88) malaria study in Cameroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine. It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax). It has also been studied as a potential anticancer drug, and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1322200106 under CC BY-SA 4.0; modifications have been made.